The Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a $505.3 million single-award Indefinite Delivery Contract (IDC) to Alvogen, Inc. to deliver the antiviral drug oseltamivir phosphate to the Strategic National Stockpile. This IDC, which has an ultimate completion date of February 6, 2025, allows ASPR to issue task orders to Alvogen for the procurement and distribution of this essential medical countermeasure to support federal pandemic preparedness.
Under this contract, ASPR has issued two task orders to Alvogen. The first, a $61.3 million firm-fixed price delivery order, will fund readiness costs for the first two years and one-time upfront fees to establish year one capabilities under ASPR's Antiviral Drug Purchase & Distribution program. The second task order, valued at $40 million, directs Alvogen to deliver oseltamivir phosphate to the Strategic National Stockpile storage locations in Morristown, New Jersey by August 2024. These awards illustrate Alvogen's role as a key supplier supporting ASPR's efforts to maintain critical stockpiles of antiviral medications for public health emergencies.
Generated 9/7/24, 11:00 AM